Litcius/Paper detail

KarXT for schizophrenia–effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council

Avery McKenna, Jeffrey A. Tice, Melanie D. Whittington, Abigail C. Wright, Marina Richardson, Finn Raymond, Steven D. Pearson, David M. Rind, Foluso Agboola

2024Journal of Managed Care & Specialty Pharmacy12 citationsDOIOpen Access PDF

Topics & Concepts

Advisory committeePublic fundingSchizophrenia (object-oriented programming)New englandMedicineValue (mathematics)Comparative effectiveness researchClinical effectivenessPolitical sciencePublic administrationPsychiatryFamily medicineAlternative medicineLawComputer scienceInternal medicinePathologyMachine learningPoliticsSchizophrenia research and treatmentHealth Systems, Economic Evaluations, Quality of LifeMental Health and Psychiatry
KarXT for schizophrenia–effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council | Litcius